The Study of the Natural Way of Development of External Pancreatic Fistulas in Children with Necrotizing Pancreatitis
1 other identifier
observational
26
1 country
1
Brief Summary
The external pancreatic fistula (EPF) is characterized by the leakage of pancreatic juice outward through an area of skinor through a drainage tube. The leakage of pancreatic juice occurs due to the rupture of the pancreatic duct (PD) caused by the destruction of pancreatic tissue. EPF can cause deterioration in the patient's condition due to the leakage of protein-rich pancreatic juice outward, as well as the increased risk of skin irritation and infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 11, 2024
CompletedFirst Submitted
Initial submission to the registry
November 20, 2024
CompletedFirst Posted
Study publicly available on registry
November 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 18, 2025
CompletedFebruary 20, 2025
February 1, 2025
2 months
November 20, 2024
February 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The duration of pancreatic fistula functioning
based on testing serum lipase and/or amylase concentrations in drained fluid, imaging results: ultrasound (US), spiral computed tomography (SCT), magnetic resonance imaging (MRI), fistolography
From the day of surgery to the end of treatment (9 months)
Secondary Outcomes (7)
The level of damage to the main pancreatic duct
From the day of surgery to the end of treatment (9 months)
The duration of hospital stay
From the day of surgery to the end of treatment (9 months)
The mortality
From enrollment to the end of treatment (9 month)
The dynamics of the total protein
From enrollment to the end of treatment (9 month)
The effect of the etiologic factor on the duration of the external pancreatic fistula functioning
From enrollment to the end of treatment (9 month)
- +2 more secondary outcomes
Study Arms (1)
children with external pancreatic fistula
children who have suffered acute necrotizing pacreatitis and undergone drainage of parapancreatic accumulations, with the development of an external pancreatic fistula
Interventions
Only data will be taken of patient's file.
Eligibility Criteria
Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky
You may qualify if:
- Patient or legal representative consent
- External pancreatic fistula
- Age from 0-18 years
- Moderate severe (MSAP) or severe acute pancreatitis (SAP) according to Atlanta criteria revisited in 2012
- Acute Pancreatitis was defined in case of the presence of at least two of the three criteria according to the classification developed by the INSPPIRE (International Study Group of Pediatric Pancreatitis: In Search for a Cure) group: abdominal pain consistent with the diagnostic hypothesis; serum amylase and/or lipase increased by ≥3 times; imaging results typical of AP: abdominal ultrasound and/or contrast-enhanced CT.
You may not qualify if:
- Mild acute pancreatitis
- Chronic pancreatitis
- No consent from patient or legal representative
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky
Moscow, 129110, Russia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Dmitriy А Pyhteev, PhD
Head of the Department of Pediatric Surgery
- PRINCIPAL INVESTIGATOR
Leonid M Elin
Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 20, 2024
First Posted
November 26, 2024
Study Start
November 11, 2024
Primary Completion
January 10, 2025
Study Completion
February 18, 2025
Last Updated
February 20, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share
A complete dataset can be provided upon reasoned request